Novae, the other remaining "small-cap" player in the publicly listed composite, enjoyed only a modest uplift in its share price after the Hardy deal was announced, despite analysts touting it as the most likely beneficiary.
Novae, the other remaining "small-cap" player in the publicly listed composite, enjoyed only a modest uplift in its share price after the Hardy deal was announced, despite analysts touting it as the most likely beneficiary.